BridgeMD
Compares treatment options for Early Abortion
Official title Comparison of Surgical Management of Early Pregnancy Loss by Suction Curettage Versus Hysteroscopy in Patients Undergoing In-vitro Fertilization (IVF)
ClinicalTrials.gov ID: NCT07143578
What this study is testing
- What it's testing
- Early pregnancy loss occurs in \~15% of pregnancies. The treatment options include surgical uterine evacuation by suction curettage, medical management with misoprostol, or conservative management without interventions.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Diagnosis of early pregnancy loss up to 10 weeks' gestation, based on last menstrual period or ultrasound.
- Pregnancy conceived through assisted reproductive techniques (in vitro fertilization, IVF).
- Ability to provide informed consent, and proficiency in reading and writing Hebrew.
You likely can't join if
- Heavy vaginal bleeding or diagnosis of incomplete abortion.
- Signs of infection and/or suspicion of septic abortion
- Known uterine anomalies- including septate, bicornuate, unicornuate, or didelphys uterus.
- Prior medical or surgical treatment during the current pregnancy
- History of intrauterine adhesions
- History of ≥ 3 prior miscarriages.
See the full eligibility criteria
- Diagnosis of early pregnancy loss up to 10 weeks' gestation, based on last menstrual period or ultrasound.
- Pregnancy conceived through assisted reproductive techniques (in vitro fertilization, IVF).
- Ability to provide informed consent, and proficiency in reading and writing Hebrew.
- Heavy vaginal bleeding or diagnosis of incomplete abortion.
- Signs of infection and/or suspicion of septic abortion
- Known uterine anomalies- including septate, bicornuate, unicornuate, or didelphys uterus.
- Prior medical or surgical treatment during the current pregnancy
- History of intrauterine adhesions
- History of ≥ 3 prior miscarriages.
- History of ≥ 3 prior cesarean sections.
- History of myomectomy via abdominal or hysteroscopic approach.
The study team makes the final eligibility decision.
Where it's taking place
- Be’er Ya‘aqov, Israel
- Ramat Gan, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Be’er Ya‘aqov, Israel; Ramat Gan, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.